Progrès thérapeutiques dans le lymphome de Hodgkin en rechute
You don't have permission to view the content
Les lymphomes Hodgkiniens des patients âgés
You don't have permission to view the content
Stratégies de traitement des Maladies de Hodgkin de haut risque en 2023
You don't have permission to view the content
Traitement des lymphomes de Hodgkin localisés
You don't have permission to view the content
Place de la radiothérapie dans le Lymphome de Hodgkin
You don't have permission to view the content
Rôle de la TEP/TDM dans la prise en charge des lymphomes de Hodgkin
You don't have permission to view the content
Biologie du lymphome de Hodgkin classique : quelles implications cliniques ?
You don't have permission to view the content
La commission Hodgkin du LYSA
You don't have permission to view the content
Repenser la protection des patients hémophiles
You don't have permission to view the content
La thérapie génique dans l’hémophilie : évolution du parcours multidisciplinaire centré sur le patient.
You don't have permission to view the content
French 
English 